Dyslipidemia Flashcards

1
Q

Omega-3 MOA

A
  • Lowers TG by 60%

- Unclear how exactly - decreases hepatic circulation of TGs OR decreases TG synthesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

ADEs of omega 3

A

Fishy burp

Indigestion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

When are omega 3s given?

A

TG over 500 mg/dL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Cholesterol absorption inhibitor MOA and examples

A

Decrease intestinal absorption of dietary and biliary cholesterol
(Ezetimibe)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Metabolism of cholesterol absorption inhibitors

A

Glucuronidation w/an active metabolite

advantage - NO CYP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Which lipid lowering med is metabolized via glucuronidation (therefore no CYP interactions)?

A

Cholesterol absorption inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Cholesterol absorption inhibitors and ASCVD risk

A

Lowers LDL but NOT proven to lower ASCVD risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Fibrates MOA and examples

A
  • Activate PPAR-alpha (metabolism/catabolism of lipids)

- Gemfibrozil, fenofibrate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Nicotinic acid MOA

A

Decreases TG synthesis (maybe in adipose tissue?)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

ADEs of nicotinic acids

A

Flushing, N/V, myopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How to combat flushing with nicotinic acid?

A

Take full dose of aspirin (325 mg)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Bile acid sequestrants MOA and examples

A
  • Anion exchange resins that bind to bile acids (excreted in feces)
  • Cholestyramine, colestipol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How are bile acid sequestrants metabolized?

A

Not absorbed or metabolized (excreted in feces)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

ADEs of bile acid sequestrants

A

GI - flatulence, abdominal pain, constipation, N/V

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Statins MOA

A

Inhibit HMG-CoA reductase (rate limiting step of cholesterol synthesis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

ADEs of statins

A

Dizziness, HA, abdominal pain, myopathy

17
Q

Statins lowest to highest potency

A

Fat People Love Seconds At Restaurants

also the order of short to long half life

18
Q

Which statin is NOT CYP metabolized?

A

Pravastatin (sulfation)

19
Q

Which statin has LOW protein binding?

A

Pravastatin

20
Q

Which statins are NOT lipophilic?

A

Pravastatin

Rosuvastatin

21
Q

Substances that INCREASE statin concentrations

A
Nicotinic acid, fibrates
Azole antifungals
Macrolide abx
Amiodarone
Grapefruit juice
ETOH
22
Q

What labs should be checked at baseline prior to a lipid lowering med being added?

A

Fasting lipid panel
ALT
CK
Glucose (fasting or A1c)

23
Q

What lab should be checked at baseline prior to adding niacin?

A

Uric acid

24
Q

What lab should be checked at baseline prior to adding bile acid sequestrants?

A

TGs

25
Q

What lab should be checked at baseline prior to adding fibrates?

A

Serum Cr or GFR

26
Q

Factors useful for assessing ASCVD risk

A

Family hx
CRP over 2
CAC over 300
ABI less than 0.9

27
Q

Factors that are NOT useful for assessing ASCVD risk

A
ApoB
CKD
Albuminuria
Cardiorespiratory fitness
Carotid intima media thickness (CIMT)
28
Q

How should adults 20-79 yo w/o current ASCVD be screened?

A

Assess traditional risk factors every 4 to 6 years

29
Q

How should adults 40-79 yo w/o current ASCVD be screened?

A

Estimate 10 yr ASCVD risk every 4-6 years

30
Q

Patient education on prescribing a statin?

A

It is to reduce risk of heart attack and stroke

31
Q

Patients on a statin should contact provider when what occurs?

A

Unexplained muscle pain

Change in urine color (dark brown)

32
Q

Safety monitoring of statins

A
  • ALT and AST (only as needed)

- Myopathy symptoms (test CK as needed)

33
Q

What is the goal of treatment if TGs are over 1000 mg/dL?

A

Emergent! Avoid acute pancreatitis

  • Goal is to decrease TG levels rather than long term prevention of ASCVD
  • Use fibrates (niacin and omega 3 can also be considered)
34
Q

How is the ASCVD 10 yr risk used?

A

ONLY in statin naive patients

35
Q

What intensity statin in 40-75 yo and ASCVD over 7.5%?

A

Moderate OR high intensity

36
Q

What intensity statin in 40-75 yo with DM?

A

Moderate intensity

37
Q

What intensity statin in 21 yo or older and LDL over 190?

A

High